Mercado Global del Tratamiento de la Lesión Renal Aguda - Por Tipo (Lesión Renal Aguda Prerrenal, Intrínseca, Postrenal, Otros); Por Tipo de Tratamiento (Diálisis, Tratamiento Farmacológico); Por Usuario Final (Hospitales, Clínicas Especializadas, Centros Quirúrgicos Ambulatorios Otros); Por Región (América del Norte, Europa, Asia Pacífico, América Latina, Medio Oriente y África); Dinámica del Mercado (2026-2035) y Panorama Competitivo

USD 7,18 Mil Millones

Valor Histórico

7,70%

CAGR

USD 15,08 Mil Millones

Valor Pronóstico

USD 7,18 Mil Millones

Valor Histórico

7,70%

CAGR

USD 15,08 Mil Millones

Valor Pronóstico

Comprar Ahora

Language of the Report – English

Sin embargo, el informe puede estar disponible en español por un costo adicional.

1.   Preface
   1.1.   Objectives of the Study
   1.2.   Key Assumptions
   1.3.   Report Coverage – Key Segmentation and Scope
   1.4.   Research Methodology
2.   Executive Summary
3.   Acute Kidney Injury Market Overview – 8 Major Markets
   3.1.   Acute Kidney Injury Market Historical Value (2019-2025)
   3.2.   Acute Kidney Injury Market Forecast Value (2026-2035)
4.   Vendor Positioning Analysis
   4.1.   Key Vendors
   4.2.   Prospective Leaders
   4.3.   Niche Leaders
   4.4.   Disruptors
5.   Acute Kidney Injury Market: Disease Overview
   5.1.   Guidelines and Stages
   5.2.   Pathophysiology
   5.3.   Screening and Diagnosis
   5.4.   Treatment Pathway
6.   Patient Profile
   6.1.   Patient Profile Overview
   6.2.   Patient Psychology and Emotional Impact Factors
   6.3.   Risk Assessment and Treatment Success Rate
7.   Acute Kidney Injury Market - Epidemiology Scenario and Forecast – 8 Major Markets
   7.1.   8MM Epidemiology Scenario Overview (2019-2035)
   7.2.   Prevalence, by Country
       7.2.1.   United States
       7.2.2.   United Kingdom
       7.2.3.   Germany
       7.2.4.   France
       7.2.5.   Italy
       7.2.6.   Spain
       7.2.7.   India
       7.2.8.   Japan
   7.3.   Diagnosed Cases, by Country
       7.3.1.   United States
       7.3.2.   United Kingdom
       7.3.3.   Germany
       7.3.4.   France
       7.3.5.   Italy
       7.3.6.   Spain
       7.3.7.   India
       7.3.8.   Japan
   7.4.   Treatment Seeking Rate, by Country
       7.4.1.   United States
       7.4.2.   United Kingdom
       7.4.3.   Germany
       7.4.4.   France
       7.4.5.   Italy
       7.4.6.   Spain
       7.4.7.   India
       7.4.8.   Japan
8.   Acute Kidney Injury Market Landscape – 8 Major Markets
   8.1.   Acute Kidney Injury Market: Developers Landscape
       8.1.1.   Analysis by Year of Establishment
       8.1.2.   Analysis by Company Size
       8.1.3.   Analysis by Region
   8.2.   Acute Kidney Injury Market: Product Landscape
       8.2.1.   Analysis By Type
       8.2.2.   Analysis By Treatment Type
9.   Clinical Trials and Pipeline Analysis
   9.1.   Analysis by Trial Registration Year
   9.2.   Analysis by Trial Status
   9.3.   Analysis by Trial Phase
   9.4.   Analysis by Therapeutic Area
   9.5.   Analysis by Geography
   9.6.   Drug Pipeline Analysis
10.   Acute Kidney Injury Market Challenges and Unmet Needs
   10.1.   Treatment Pathway Challenges
   10.2.   Compliance and Drop-Out Analysis
   10.3.   Awareness and Prevention Gaps
11.   Cost of Treatment
12.   Acute Kidney Injury Market Dynamics
   12.1.   Market Drivers and Constraints
   12.2.   SWOT Analysis
       12.2.1.   Strengths
       12.2.2.   Weaknesses
       12.2.3.   Opportunities
       12.2.4.   Threats
   12.3.   PESTEL Analysis
       12.3.1.   Political
       12.3.2.   Economic
       12.3.3.   Social
       12.3.4.   Technological
       12.3.5.   Legal
       12.3.6.   Environment
   12.4.   Porter’s Five Forces Model
       12.4.1.   Bargaining Power of Suppliers
       12.4.2.   Bargaining Power of Buyers
       12.4.3.   Threat of New Entrants
       12.4.4.   Threat of Substitutes
       12.4.5.   Degree of Rivalry
   12.5.   Key Demand Indicators
   12.6.   Key Price Indicators
   12.7.   Industry Events, Initiatives, and Trends
   12.8.   Value Chain Analysis
13.   Acute Kidney Injury Market Segmentation (2019-2035) - 8 Major Markets
   13.1.   Acute Kidney Injury Market (2019-2035) by Type
       13.1.1.   Market Overview
       13.1.2.   Prerenal Acute Kidney Injury
       13.1.3.   Intrinsic Renal Acute Kidney Injury
       13.1.4.   Postrenal Acute Kidney Injury
   13.2.   Acute Kidney Injury Market (2019-2035) by Treatment Type
       13.2.1.   Market Overview
       13.2.2.   Dialysis
           13.2.2.1.   Intermittent Hemodialysis
           13.2.2.2.   Continuous Renal Replacement Therapy (CRRT)
           13.2.2.3.   Sustained Low-Efficiency Dialysis (SLED)
       13.2.3.   Drug Therapy
           13.2.3.1.   Antibiotics
           13.2.3.2.   Diuretics
           13.2.3.3.   Immunosuppressive Agents
   13.3.   Acute Kidney Injury Market (2019-2035) by End User
       13.3.1.   Market Overview
       13.3.2.   Hospitals
       13.3.3.   Specialty Clinics
       13.3.4.   Ambulatory Surgical Centers
       13.3.5.   Others
   13.4.   Acute Kidney Injury Market (2019-2035) by Region
       13.4.1.   Market Overview
       13.4.2.   United States
       13.4.3.   United Kingdom
       13.4.4.   Germany
       13.4.5.   France
       13.4.6.   Italy
       13.4.7.   Spain
       13.4.8.   Japan
       13.4.9.   India
14.   United States Acute Kidney Injury Market (2019-2035)
   14.1.   United States Acute Kidney Injury Market (2019-2035) by Type
       14.1.1.   Market Overview
       14.1.2.   Prerenal Acute Kidney Injury
       14.1.3.   Intrinsic Renal Acute Kidney Injury
       14.1.4.   Postrenal Acute Kidney Injury
   14.2.   United States Acute Kidney Injury Market (2019-2035) by Treatment Type
       14.2.1.   Market Overview
       14.2.2.   Dialysis
           14.2.2.1.   Intermittent Hemodialysis
           14.2.2.2.   Continuous Renal Replacement Therapy (CRRT)
           14.2.2.3.   Sustained Low-Efficiency Dialysis (SLED)
       14.2.3.   Drug Therapy
           14.2.3.1.   Antibiotics
           14.2.3.2.   Diuretics
           14.2.3.3.   Immunosuppressive Agents
   14.3.   United States Acute Kidney Injury Market (2019-2035) by End User
       14.3.1.   Market Overview
       14.3.2.   Hospitals
       14.3.3.   Specialty Clinics
       14.3.4.   Ambulatory Surgical Centers
       14.3.5.   Others
15.   United Kingdom Acute Kidney Injury Market (2019-2035)
   15.1.   United Kingdom Acute Kidney Injury Market (2019-2035) by Type
       15.1.1.   Market Overview
       15.1.2.   Prerenal Acute Kidney Injury
       15.1.3.   Intrinsic Renal Acute Kidney Injury
       15.1.4.   Postrenal Acute Kidney Injury
   15.2.   United Kingdom Acute Kidney Injury Market (2019-2035) by Treatment Type
       15.2.1.   Market Overview
       15.2.2.   Dialysis
           15.2.2.1.   Intermittent Hemodialysis
           15.2.2.2.   Continuous Renal Replacement Therapy (CRRT)
           15.2.2.3.   Sustained Low-Efficiency Dialysis (SLED)
       15.2.3.   Drug Therapy
           15.2.3.1.   Antibiotics
           15.2.3.2.   Diuretics
           15.2.3.3.   Immunosuppressive Agents
   15.3.   United Kingdom Acute Kidney Injury Market (2019-2035) by End User
       15.3.1.   Market Overview
       15.3.2.   Hospitals
       15.3.3.   Specialty Clinics
       15.3.4.   Ambulatory Surgical Centers
       15.3.5.   Others
16.   Germany Acute Kidney Injury Market (2019-2035)
   16.1.   Germany Acute Kidney Injury Market (2019-2035) by Type
       16.1.1.   Market Overview
       16.1.2.   Prerenal Acute Kidney Injury
       16.1.3.   Intrinsic Renal Acute Kidney Injury
       16.1.4.   Postrenal Acute Kidney Injury
   16.2.   Germany Acute Kidney Injury Market (2019-2035) by Treatment Type
       16.2.1.   Market Overview
       16.2.2.   Dialysis
           16.2.2.1.   Intermittent Hemodialysis
           16.2.2.2.   Continuous Renal Replacement Therapy (CRRT)
           16.2.2.3.   Sustained Low-Efficiency Dialysis (SLED)
       16.2.3.   Drug Therapy
           16.2.3.1.   Antibiotics
           16.2.3.2.   Diuretics
           16.2.3.3.   Immunosuppressive Agents
   16.3.   Germany Acute Kidney Injury Market (2019-2035) by End User
       16.3.1.   Market Overview
       16.3.2.   Hospitals
       16.3.3.   Specialty Clinics
       16.3.4.   Ambulatory Surgical Centers
       16.3.5.   Others
17.   France Acute Kidney Injury Market (2019-2035)
   17.1.   France Acute Kidney Injury Market (2019-2035) by Type
       17.1.1.   Market Overview
       17.1.2.   Prerenal Acute Kidney Injury
       17.1.3.   Intrinsic Renal Acute Kidney Injury
       17.1.4.   Postrenal Acute Kidney Injury
   17.2.   France Acute Kidney Injury Market (2019-2035) by Treatment Type
       17.2.1.   Market Overview
       17.2.2.   Dialysis
           17.2.2.1.   Intermittent Hemodialysis
           17.2.2.2.   Continuous Renal Replacement Therapy (CRRT)
           17.2.2.3.   Sustained Low-Efficiency Dialysis (SLED)
       17.2.3.   Drug Therapy
           17.2.3.1.   Antibiotics
           17.2.3.2.   Diuretics
           17.2.3.3.   Immunosuppressive Agents
   17.3.   France Acute Kidney Injury Market (2019-2035) by End User
       17.3.1.   Market Overview
       17.3.2.   Hospitals
       17.3.3.   Specialty Clinics
       17.3.4.   Ambulatory Surgical Centers
       17.3.5.   Others
18.   Italy Acute Kidney Injury Market (2019-2035)
   18.1.   Italy Acute Kidney Injury Market (2019-2035) by Type
       18.1.1.   Market Overview
       18.1.2.   Prerenal Acute Kidney Injury
       18.1.3.   Intrinsic Renal Acute Kidney Injury
       18.1.4.   Postrenal Acute Kidney Injury
   18.2.   Italy Acute Kidney Injury Market (2019-2035) by Treatment Type
       18.2.1.   Market Overview
       18.2.2.   Dialysis
           18.2.2.1.   Intermittent Hemodialysis
           18.2.2.2.   Continuous Renal Replacement Therapy (CRRT)
           18.2.2.3.   Sustained Low-Efficiency Dialysis (SLED)
       18.2.3.   Drug Therapy
           18.2.3.1.   Antibiotics
           18.2.3.2.   Diuretics
           18.2.3.3.   Immunosuppressive Agents
   18.3.   Italy Acute Kidney Injury Market (2019-2035) by End User
       18.3.1.   Market Overview
       18.3.2.   Hospitals
       18.3.3.   Specialty Clinics
       18.3.4.   Ambulatory Surgical Centers
       18.3.5.   Others
19.   Spain Acute Kidney Injury Market (2019-2035)
   19.1.   Spain Acute Kidney Injury Market (2019-2035) by Type
       19.1.1.   Market Overview
       19.1.2.   Prerenal Acute Kidney Injury
       19.1.3.   Intrinsic Renal Acute Kidney Injury
       19.1.4.   Postrenal Acute Kidney Injury
   19.2.   Spain Acute Kidney Injury Market (2019-2035) by Treatment Type
       19.2.1.   Market Overview
       19.2.2.   Dialysis
           19.2.2.1.   Intermittent Hemodialysis
           19.2.2.2.   Continuous Renal Replacement Therapy (CRRT)
           19.2.2.3.   Sustained Low-Efficiency Dialysis (SLED)
       19.2.3.   Drug Therapy
           19.2.3.1.   Antibiotics
           19.2.3.2.   Diuretics
           19.2.3.3.   Immunosuppressive Agents
   19.3.   Spain Acute Kidney Injury Market (2019-2035) by End User
       19.3.1.   Market Overview
       19.3.2.   Hospitals
       19.3.3.   Specialty Clinics
       19.3.4.   Ambulatory Surgical Centers
       19.3.5.   Others
20.   Japan Acute Kidney Injury Market (2019-2035)
   20.1.   Japan Acute Kidney Injury Market (2019-2035) by Type
       20.1.1.   Market Overview
       20.1.2.   Prerenal Acute Kidney Injury
       20.1.3.   Intrinsic Renal Acute Kidney Injury
       20.1.4.   Postrenal Acute Kidney Injury
   20.2.   Japan Acute Kidney Injury Market (2019-2035) by Treatment Type
       20.2.1.   Market Overview
       20.2.2.   Dialysis
           20.2.2.1.   Intermittent Hemodialysis
           20.2.2.2.   Continuous Renal Replacement Therapy (CRRT)
           20.2.2.3.   Sustained Low-Efficiency Dialysis (SLED)
       20.2.3.   Drug Therapy
           20.2.3.1.   Antibiotics
           20.2.3.2.   Diuretics
           20.2.3.3.   Immunosuppressive Agents
   20.3.   Japan Acute Kidney Injury Market (2019-2035) by End User
       20.3.1.   Market Overview
       20.3.2.   Hospitals
       20.3.3.   Specialty Clinics
       20.3.4.   Ambulatory Surgical Centers
       20.3.5.   Others
21.   India Acute Kidney Injury Market (2019-2035)
   21.1.   India Acute Kidney Injury Market (2019-2035) by Type
       21.1.1.   Market Overview
       21.1.2.   Prerenal Acute Kidney Injury
       21.1.3.   Intrinsic Renal Acute Kidney Injury
       21.1.4.   Postrenal Acute Kidney Injury
   21.2.   India Acute Kidney Injury Market (2019-2035) by Treatment Type
       21.2.1.   Market Overview
       21.2.2.   Dialysis
           21.2.2.1.   Intermittent Hemodialysis
           21.2.2.2.   Continuous Renal Replacement Therapy (CRRT)
           21.2.2.3.   Sustained Low-Efficiency Dialysis (SLED)
       21.2.3.   Drug Therapy
           21.2.3.1.   Antibiotics
           21.2.3.2.   Diuretics
           21.2.3.3.   Immunosuppressive Agents
   21.3.   India Acute Kidney Injury Market (2019-2035) by End User
       21.3.1.   Market Overview
       21.3.2.   Hospitals
       21.3.3.   Specialty Clinics
       21.3.4.   Ambulatory Surgical Centers
       21.3.5.   Others
22.   Regulatory Framework
   22.1.   Regulatory Overview
   22.2.   US FDA
   22.3.   EU EMA
   22.4.   Japan PMDA
   22.5.   India CDSCO
   22.6.   Others
23.   Patent Analysis
   23.1.   Analysis by Type of Patent
   23.2.   Analysis by Publication Year
   23.3.   Analysis by Issuing Authority
   23.4.   Analysis by Patent Age
   23.5.   Analysis by CPC Analysis
   23.6.   Analysis by Patent Valuation
24.   Grants Analysis
   24.1.   Analysis by Year
   24.2.   Analysis by Amount Awarded
   24.3.   Analysis by Issuing Authority
   24.4.   Analysis by Grant Application
   24.5.   Analysis by Funding Institute
   24.6.   Analysis by NIH Departments
   24.7.   Analysis by Recipient Organization
25.   Funding and Investment Analysis
   25.1.   Analysis by Funding Instances
   25.2.   Analysis by Drug Class of Funding
   25.3.   Analysis by Funding Amount
   25.4.   Analysis by Leading Players
   25.5.   Analysis by Leading Investors
   25.6.   Analysis by Geography
26.   Strategic Initiatives
   26.1.   Analysis by Partnership Instances
   26.2.   Analysis by Drug Class of Partnership
   26.3.   Analysis by Leading Players
   26.4.   Analysis by Geography
27.   Supplier Landscape
   27.1.   Market Share Analysis, By Region for Top 5 Companies
   27.2.   Pfizer Inc .
       27.2.1.   Financial Analysis
       27.2.2.   Product Portfolio
       27.2.3.   Demographic Reach and Achievements
       27.2.4.   Company News and Development
       27.2.5.   Certifications
   27.3.   Baxter International, Inc .
       27.3.1.   Financial Analysis
       27.3.2.   Product Portfolio
       27.3.3.   Demographic Reach and Achievements
       27.3.4.   Company News and Development
       27.3.5.   Certifications
   27.4.   Asahi Kasei Medical Co., Ltd.
       27.4.1.   Financial Analysis
       27.4.2.   Product Portfolio
       27.4.3.   Demographic Reach and Achievements
       27.4.4.   Company News and Development
       27.4.5.   Certifications
   27.5.   B. Braun Melsungen AG
       27.5.1.   Financial Analysis
       27.5.2.   Product Portfolio
       27.5.3.   Demographic Reach and Achievements
       27.5.4.   Company News and Development
       27.5.5.   Certifications
   27.6.   Quark Pharmaceuticals, Inc.
       27.6.1.   Financial Analysis
       27.6.2.   Product Portfolio
       27.6.3.   Demographic Reach and Achievements
       27.6.4.   Company News and Development
       27.6.5.   Certifications
   27.7.   Asahi Kasei Medical Co., Ltd.
       27.7.1.   Financial Analysis
       27.7.2.   Product Portfolio
       27.7.3.   Demographic Reach and Achievements
       27.7.4.   Company News and Development
       27.7.5.   Certifications
   27.8.   B. Braun Melsungen AG
       27.8.1.   Financial Analysis
       27.8.2.   Product Portfolio
       27.8.3.   Demographic Reach and Achievements
       27.8.4.   Company News and Development
       27.8.5.   Certifications
   27.9.   Quark Pharmaceuticals, Inc.
       27.9.1.   Financial Analysis
       27.9.2.   Product Portfolio
       27.9.3.   Demographic Reach and Achievements
       27.9.4.   Company News and Development
       27.9.5.   Certifications
28.   Acute Kidney Injury Market - Distribution Model (Additional Insight)
   28.1.   Overview
   28.2.   Potential Distributors
   28.3.   Key Parameters for Distribution Partner Assessment
29.   Key Opinion Leaders (KOL) Insights (Additional Insight)
30.   Payment Methods (Additional Insight)
   30.1.   Government Funded
   30.2.   Private Insurance
   30.3.   Out-of-Pocket

*The list of players in the competitive landscape section can be customised or made more exhaustive based on your specific requirements.*

Contenidos

Language of the Report – English

Sin embargo, el informe puede estar disponible en español por un costo adicional.

*The list of players in the competitive landscape section can be customised or made more exhaustive based on your specific requirements.*

Comprar el Informe

Excel Data Set

Obtenga el conjunto de datos de Excel de este informe. También puede pagar el dividendo para leer el informe detallado completo. Para obtener más información, consulte la tabla de precios a continuación.

USD 3299

USD 2969

Datos completos en formato Excel para un usuario
Impresión no permitida
Entrega por Email
Personalización limitada gratuita (pre-venta)
Soporte de analista post venta
Descuento del 50% en la Próxima Actualización

Usuario Único

Obtenga acceso al informe completo en formato PDF en un sistema con una única dirección de correo electrónico con algunas limitaciones. Para obtener más información, consulte la tabla de precios a continuación.

USD 5499

USD 4949

Restringido a un usuario
Solo una impresión
Disponible en PDF
Personalización limitada gratuita (pre-venta)
Soporte de analista post venta
Descuento del 50% en la Próxima Actualización

Cinco Usuarios

Obtenga acceso al informe completo en formato PDF con cinco direcciones de correo electrónico, junto con personalizaciones limitadas gratuitas en la etapa de pre-venta y el soporte post-venta de nuestros analistas. Para obtener más información, consulte la tabla de precios a continuación.

USD 6999

USD 5949

Restringido a cinco usuarios
Una impresión por usuario
Disponible en PDF
Personalización limitada gratuita (pre-venta)
Soporte de analista post venta
Descuento del 50% en la Próxima Actualización

Multiusuario

Obtenga acceso ilimitado al informe en formatos PPT y PDF para múltiples usuarios en su organización, junto con personalizaciones limitadas gratuitas en la etapa de pre-venta, el soporte post-venta de nuestros analistas y una opción de actualización gratuita del informe dentro de 180 días de la compra. Para obtener más información, consulte la tabla de precios a continuación.

USD 8199

USD 6969

Usuarios ilimitados dentro de la organización
Impresiones ilimitadas
Disponible en PDF
Personalización limitada gratuita (pre-venta)
Soporte de analista post venta
Descuento del 50% en la Próxima Actualización

¿Cualquier Pregunta? Hable con un Analista

Ver una Muestra

Se le olvidó algo? Pregunte Ahora

¿Por Qué Informes de Expertos?

Nuestro equipo experto de analistas ofrecerá soporte completo y resolverá cualquier consulta sobre el informe, antes y después de la compra.

La Gente Adecuada
Somos técnicamente excelentes, estratégicos, prácticos, experimentados y eficientes; nuestros analistas son cuidadosamente seleccionados en base a tener los atributos correctos para trabajar exitosamente y ejecutar proyectos según sus expectativas.
Metodología Correcta
Aprovechamos nuestra tecnología de vanguardia, acceso a bases de datos confiables y conocimiento de los modelos de mercado actuales para ofrecer soluciones de investigación adaptadas a sus necesidades y mantenerlo a la vanguardia.
Precio Justo
Realizamos investigaciones exhaustivas y de alta calidad a precios inmejorables y razonables que demuestran nuestra comprensión de su estructura de recursos. También ofrecemos descuentos atractivos en nuestros próximos informes.
Apoyo Adecuado
Nuestro equipo de analistas expertos está a su completa disposición para proporcionarle resultados óptimos y personalizados que satisfagan sus necesidades precisas dentro del plazo especificado y ayudarle a comprender mejor la industria.

Contenidos

Comprar el Informe

Excel Data Set

USD 3299

USD 2969

Datos completos en formato Excel para un usuario
Impresión no permitida
Entrega por Email
Personalización limitada gratuita (pre-venta)
Soporte de analista post venta
Descuento del 50% en la Próxima Actualización

Usuario Único

USD 5499

USD 4949

Restringido a un usuario
Solo una impresión
Disponible en PDF
Personalización limitada gratuita (pre-venta)
Soporte de analista post venta
Descuento del 50% en la Próxima Actualización

Cinco Usuarios

USD 6999

USD 5949

Restringido a cinco usuarios
Una impresión por usuario
Disponible en PDF
Personalización limitada gratuita (pre-venta)
Soporte de analista post venta
Descuento del 50% en la Próxima Actualización

Multiusuario

USD 8199

USD 6969

Usuarios ilimitados dentro de la organización
Impresiones ilimitadas
Disponible en PDF
Personalización limitada gratuita (pre-venta)
Soporte de analista post venta
Descuento del 50% en la Próxima Actualización

Tabla de Contenidos

Tabla de Contenidos

Comprar el Informe

Excel Data Set

Usuario Único

Cinco Usuarios

Multiusuario

¿Cualquier Pregunta? Hable con un Analista

Ver una Muestra

Se le olvidó algo? Pregunte Ahora

La Gente Adecuada

Metodología Correcta

Precio Justo

Apoyo Adecuado

Comprar el Informe

Excel Data Set

Usuario Único

Cinco Usuarios

Multiusuario

¿Cualquier Pregunta? Hable con un Analista

Ver una Muestra

Se le olvidó algo? Pregunte Ahora

La Gente Adecuada

Metodología Correcta

Precio Justo

Apoyo Adecuado